An Antiapoptotic Role for Gastrin and Gastrin/CCK-2 Receptor in Barrett's Esophagus

Cancer Research

Volumn 64, Issue 6, 2004, Pages 1915-1919

  Harris, Joseph C ^a   Clarke, Philip A ^a   Awan, Altaf ^a   Jankowski, Janusz ^b   Watson, Susan A ^a,c  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; GASTRIN; PROTEIN KINASE B;

APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; BARRETT ESOPHAGUS; CELL LINE; CONTROLLED STUDY; ENDOCRINE FUNCTION; ENZYME ACTIVATION; ESOPHAGUS; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE METAPLASIA; MALIGNANT TRANSFORMATION; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; APOPTOSIS; BARRETT ESOPHAGUS; BENZODIAZEPINES; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; GASTRINS; HORMONE ANTAGONISTS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, CHOLECYSTOKININ B; TUMOR CELLS, CULTURED;

EID: 1542615086     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-2713     Document Type: Article

References (12)

1. Jankowski JA, Harrison RF, Perry I, Balkwill F, Tselepis C. Barrett's metaplasia. Lancet 2000;356:2079-85.
2. Geobes K, Van Eyken P. The diagnosis of dysplasia and malignancy in Barrett's oesophagus. Histopathology 2000;37(2):99-107.
3. Varro A, Noble PJ, Wroblewski LE, Bishop L, Dockray GJ. Gastrin-cholecystokinin(B) receptor expression in AGS cells is associated with direct inhibition and indirect stimulation of cell proliferation via paracrine activation of the epidermal growth factor receptor. Gut 2002;50(6):827-33.
4. Guo YS, Cheng JZ, Jin GF, Gutkind JS, Hellmich MR, Townsend CM Jr. Gastrin stimulates cyclooxygenase-2 expression in intestinal epithelial cells through multiple signaling pathways. Evidence for involvement of ERK5 kinase and transactivation of the epidermal growth factor receptor. J Biol Chem 2002;277(50):48755-63.
5. Clarke PA, Evans S, McWilliams D, Watson SA. Angiogenic potential of HUVEC cells is increased by amidated and glycine-extended gastrin-17. Gastroenterology 2002;122(S1):S914.
6. Todisco A, Ramamoorthy S, Witham T, et al. Molecular mechanisms for the anti-apoptotic action of gastrin. Am J Physiol Gastrointest Liver Physiol 2001;280:G298-307.
7. Nemeth J, Varro A, Bridson J, Walker R, Dockray GJ. Increased tissue concentrations of the gastrin precursor in patients treated with omeprazole. Eur J Clin Investig 1992;22:638-44.
8. Hellmich MR, Rui X-L, Hellmich HL, Fleming RYD, Evers BM, Townsend CM Jr. Human colorectal cancers express a constitutively active cholecystokinin-B/gastrin receptor that stimulates cell growth. J Biol Chem 2000;275(41):32122-8.
9. Cross TG, Scheel-Toellner D, Henriquez NV, Deacon E, Salmon M, Lord JM. Serine/threonine protein kinases and apoptosis. Exp Cell Res 2000;256(1):34-41.
10. McWilliams DF, Watson SA, Crosbee DM, Michaeli D, Seth T. Co-expression of gastrin and gastrin receptors (CCK-B and ΔCCK-B) in gastrointestinal tumour cell lines. Gut 1998;42:795-8.
11. Watson SA, Clarke PA, Smith AM, et al. Expression of CCKB/gastrin receptor isoforms in gastrointestinal tumour cells. Int J Cancer 1998;77:572-7.
12. Haigh CR, Attwood SE, Thompson DG, et al. Gastrin induces proliferation in Barrett's metaplasia through activation of the CCK2 receptor. Gastroenterology 2003;124(3):615-25.